• Dosage of Despej in details
• Despej interactions
• Despej reviews

Dosage of Despej in details

Despej Dosage

Generic name: Despej 5mg

Dosage form: tablet, film coated; oral solution

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Although an orally disintegrating tablet formulation of Despej may be available in the marketplace, Despej® RediTabs® Tablets are no longer marketed.

Despej Tablets,

Oral Solution, or RediTabs Tablets may be taken without regard to meals. Place Despej (Despej) RediTabs Tablets on the tongue and allow to disintegrate before swallowing. Tablet disintegration occurs rapidly. Administer with or without water. Take tablet immediately after opening the blister.

The age-appropriate dose of Despej

Oral Solution should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (½ teaspoon).

Adults and Adolescents 12 Years of Age and Over

The recommended dose of Despej Tablets or Despej Tablets is one 5-mg tablet once daily. The recommended dose of Despej

Oral Solution is 2 teaspoonfuls (5 mg in 10 mL) once daily.

Children 6 to 11 Years of Age

The recommended dose of Despej

Oral Solution is 1 teaspoonful (2.5 mg in 5 mL) once daily. The recommended dose of Despej Tablets is one 2.5-mg tablet once daily.

Children 12 Months to 5 Years of Age

The recommended dose of Despej

Oral Solution is ½ teaspoonful (1.25 mg in 2.5 mL) once daily.

Children 6 to 11 Months of Age

The recommended dose of Despej

Oral Solution is 2 mL (1 mg) once daily.

Adults with Hepatic or Renal Impairment

In adult patients with liver or renal impairment, a starting dose of one 5-mg tablet every other day is recommended based on pharmacokinetic data. Dosing recommendation for children with liver or renal impairment cannot be made due to lack of data.

More about Despej (Despej)

• Side Effects
• During Pregnancy or Breastfeeding
• Dosage Information
• Drug Images
• Drug Interactions
• Support Group
• Pricing & Coupons
• En Espanol
• 5 Reviews - Add your own review/rating
• Generic Availability

Consumer resources

• Despej
• Despej syrup
• Despej (Advanced Reading)

Professional resources

• Despej (AHFS Monograph)
• Despej (FDA)

Other formulations

• Despej-D 24 Hour
• Despej-D 12 Hour
• Despej

Related treatment guides

• Allergic Rhinitis
• Urticaria

What other drugs will affect Despej?

There may be other drugs that can interact with Despej. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Despej interactions

Inhibitors Of Cytochrome P450 3A4

In controlled clinical studies co-administration of Despej with ketoconazole, erythromycin, or azithromycin resulted in increased plasma concentrations of Despej and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Despej.

Fluoxetine

In controlled clinical studies co-administration of Despej with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), resulted in increased plasma concentrations of Despej and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Despej.

Cimetidine

In controlled clinical studies co-administration of Despej with cimetidine, a histamine H2-receptor antagonist, resulted in increased plasma concentrations of Despej and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Despej.

Drug Abuse And Dependence

There is no information to indicate that abuse or dependency occurs with Despej Tablets.

References

1. DailyMed. "DESLORATADINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. FDA/SPL Indexing Data. "FVF865388R: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. MeSH. "Cholinergic Antagonists". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Despej are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Despej. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 14 here

Information checked by Dr. Sachin Kumar, MD Pharmacology